Bioventus (BVS)
(Delayed Data from NSDQ)
$3.98 USD
-0.09 (-2.21%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.98 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | 0.07 |
Last EPS Surprise | 16.67% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.16 |
Next Year | 0.40 |
EPS (TTM) | 0.00 |
P/E (F1) | 24.88 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 115.51M | 136.63M | 529.08M | 559.30M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 115.51M | 136.63M | 529.08M | 559.30M |
Low Estimate | 115.51M | 136.63M | 529.08M | 559.30M |
Year ago Sales | 119.06M | 137.07M | 512.34M | 529.08M |
Year over Year Growth Est. | -2.98% | -0.32% | 3.27% | 5.71% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | 0.07 | 0.16 | 0.40 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.05 | 0.07 | 0.16 | 0.40 |
Low Estimate | -0.05 | 0.07 | 0.16 | 0.40 |
Year ago EPS | -0.26 | 0.14 | 0.02 | 0.16 |
Year over Year Growth Est. | 80.77% | -50.00% | 700.00% | 150.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | 0.07 | 0.16 | 0.40 |
7 Days Ago | -0.05 | 0.07 | 0.16 | 0.40 |
30 Days Ago | -0.05 | 0.07 | 0.16 | 0.40 |
60 Days Ago | 0.03 | 0.15 | 0.38 | 0.57 |
90 Days Ago | 0.03 | 0.15 | 0.38 | 0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | 0.07 | 0.16 | 0.40 |
Zacks Consensus Estimate | -0.05 | 0.07 | 0.16 | 0.40 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.07 | 0.05 | 0.14 | -0.26 | NA |
Estimate | 0.06 | 0.06 | 0.03 | -0.11 | NA |
Difference | 0.01 | -0.01 | 0.11 | -0.15 | -0.01 |
Surprise | 16.67% | -16.67% | 366.67% | -136.36% | 57.58% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more